Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
CMPX	COMPASS THERAPEUTICS INC	$0.77	-5.61%	1.98%	-9.68%	-65.75%	-60.71%	-83.77%	-44.71%	-78.50%	N/A	$6.88	$0.67	88.75%	15.35%	1.03	1,550,000	-15.90%
IMUX	IMMUNIC INC	$7.52	-3.47%	-2.97%	9.14%	-54.64%	-41.93%	5.54%	-22.42%	-91.87%	-99.70%	$17.43	$5.06	56.86%	48.56%	1.18	105,000	-52.05%
LBRX	LB PHARMACEUTICALS INC	$43.01	1.30%	2.38%	23.63%	-2.85%	33.12%	188.66%	N/A	N/A	N/A	$50.16	$15.13	14.25%	184.27%	0.76	330,000	-24.83%
OCUL	OCULAR THERAPEUTIX INC	$6.21	-1.11%	-5.84%	-14.23%	-38.51%	-32.79%	-44.50%	181.00%	-12.29%	-17.09%	$16.44	$6.00	62.23%	3.59%	1.51	2,489,000	6.50%
VRCA	VERRICA PHARMACEUTICALS INC	$3.56	-4.30%	11.60%	-0.56%	-26.75%	-51.70%	-8.01%	-88.17%	-97.04%	N/A	$9.82	$3.08	63.75%	15.58%	1.03	18,700	-82.36%
GTBP	GT BIOPHARMA INC	$3.72	-3.13%	-15.84%	-42.77%	-49.97%	-52.41%	-79.61%	-97.82%	-99.90%	N/A	$23.60	$3.60	84.24%	3.33%	1.01	67,000	-11.84%
TVRD	TVARDI THERAPEUTICS INC	$1.18	2.16%	23.17%	13.46%	-33.33%	-70.13%	-71.29%	-97.22%	-99.79%	-99.65%	$5.69	$0.77	79.26%	52.65%	1.02	74,000	-55.69%
LXEO	LEXEO THERAPEUTICS INC	$2.87	-1.37%	-0.69%	4.74%	-42.14%	-50.17%	-68.08%	-72.72%	N/A	N/A	$10.99	$2.55	73.89%	12.55%	1.88	442,000	-74.26%
MLYS	MINERALYS THERAPEUTICS INC	$15.33	-1.10%	0.00%	-27.00%	-41.24%	-42.93%	-65.39%	141.04%	N/A	N/A	$45.62	$14.78	66.39%	3.72%	1.04	1,308,000	-55.36%
OSTX	OS THERAPIES INC	$0.75	-0.67%	-25.50%	-48.62%	-53.44%	-58.38%	-59.07%	N/A	N/A	N/A	$2.25	$0.58	66.89%	28.45%	1.06	822,000	-38.66%
XENE	XENON PHARMACEUTICALS INC	$40.48	-1.26%	3.34%	17.61%	-36.98%	-27.56%	1.10%	36.30%	27.78%	381.90%	$72.66	$33.38	44.29%	21.27%	0.94	581,000	-52.53%
MBRX	MOLECULIN BIOTECH INC	$7.87	-2.36%	-9.54%	-9.58%	-31.12%	-81.61%	-96.53%	-99.82%	-99.96%	-99.99%	$229.40	$3.23	96.57%	143.80%	0.85	9,900	-76.43%
EDSA	EDESA BIOTECH INC	$1.94	-6.73%	-9.35%	-31.93%	-64.27%	-87.27%	12.14%	-23.92%	-95.96%	-99.67%	$20.32	$0.72	90.45%	169.44%	0.84	510,000	-0.97%
UPB	UPSTREAM BIO INC	$2.78	-2.80%	-13.93%	-21.69%	-59.77%	-70.30%	-88.09%	N/A	N/A	N/A	$33.68	$2.68	91.75%	3.73%	1.24	891,000	-64.77%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$47.78	1.34%	-17.85%	-17.80%	-44.18%	-38.65%	16.14%	83.98%	-27.50%	981.00%	$95.49	$37.06	49.96%	28.93%	1.61	3,114,000	44.37%
LRMR	LARIMAR THERAPEUTICS INC	$3.02	11.85%	26.36%	39.81%	-29.27%	-26.34%	-8.21%	26.36%	-72.50%	-93.05%	$6.42	$1.92	52.96%	57.70%	1.20	2,531,000	108.83%
MPLT	MAPLIGHT THERAPEUTICS INC	$7.25	2.55%	4.62%	-7.94%	-37.39%	-76.36%	-49.23%	N/A	N/A	N/A	$40.43	$6.06	82.07%	19.64%	1.01	368,000	38.35%
ATYR	ATYR PHARMA INC	$6.11	-1.69%	-3.86%	-24.10%	-72.40%	-61.45%	-78.61%	-86.31%	-98.23%	-99.69%	$44.40	$4.07	86.25%	50.07%	1.00	38,000	7.95%
NKTX	NKARTA INC	$1.19	-5.93%	-31.21%	-43.33%	-48.26%	-61.11%	-36.70%	-37.70%	-93.48%	N/A	$3.72	$1.11	67.97%	7.69%	1.58	1,394,000	35.74%
LENZ	LENZ THERAPEUTICS INC	$4.13	0.98%	18.00%	21.47%	-10.22%	-48.70%	-84.41%	-74.35%	-94.99%	N/A	$32.10	$2.80	87.13%	47.50%	1.37	749,000	-3.10%
BCAX	BICARA THERAPEUTICS INC	$10.02	-0.89%	15.84%	-42.21%	-57.60%	-52.26%	-29.73%	N/A	N/A	N/A	$30.99	$7.87	67.67%	27.32%	1.44	1,520,000	-19.66%
RCKT	ROCKET PHARMACEUTICALS INC	$2.30	-3.77%	-3.56%	0.00%	-31.14%	-36.11%	-27.44%	-88.21%	-91.12%	-91.79%	$5.45	$2.17	57.80%	6.24%	1.68	1,783,000	86.70%
EVMN	EVOMMUNE INC	$7.63	-4.86%	14.74%	29.76%	-45.77%	-67.24%	-58.12%	N/A	N/A	N/A	$33.20	$4.94	77.02%	54.45%	1.06	723,000	-36.63%
PALI	PALISADE BIO INC	$1.12	-1.75%	-0.88%	-23.81%	-47.91%	-40.11%	-40.11%	-85.82%	-99.94%	-100.00%	$2.86	$1.08	60.77%	3.70%	1.22	1,458,000	48.02%
BEAM	BEAM THERAPEUTICS INC	$22.83	-4.99%	-13.56%	-6.55%	-13.88%	-28.32%	5.40%	4.06%	-73.59%	N/A	$38.26	$20.23	40.33%	12.85%	2.05	2,046,000	35.32%
INBX	INHIBRX BIOSCIENCES INC	$83.30	-5.07%	-1.44%	-4.34%	-14.13%	-29.38%	11.63%	N/A	N/A	N/A	$155.29	$57.30	46.36%	45.38%	1.41	245,000	8.41%
SPRO	SPERO THERAPEUTICS INC	$1.00	0.00%	-2.91%	-13.04%	-19.35%	-59.02%	-59.02%	-9.91%	-93.91%	N/A	$3.08	$0.95	67.53%	5.04%	0.80	357,000	8.84%
OLMA	OLEMA PHARMACEUTICALS INC	$7.56	0.53%	3.14%	7.69%	-28.07%	-44.33%	-4.79%	-48.75%	-71.24%	N/A	$36.26	$6.24	79.15%	21.25%	1.26	1,697,000	-15.02%
TNGX	TANGO THERAPEUTICS INC	$25.50	2.62%	18.60%	14.76%	-0.58%	-0.04%	230.31%	236.86%	88.89%	N/A	$34.39	$7.69	25.85%	231.60%	1.34	2,678,000	-23.22%
IVVD	INVIVYD INC	$0.58	2.65%	3.37%	-9.91%	-15.16%	-60.41%	-67.12%	-61.20%	-97.14%	N/A	$3.07	$0.53	81.04%	10.23%	1.41	3,154,000	16.08%
IMNM	IMMUNOME INC	$18.77	0.37%	0.32%	6.77%	-28.96%	-15.45%	13.69%	127.79%	5.57%	N/A	$30.06	$16.41	37.56%	14.38%	1.46	951,000	-42.68%
CNSY	CERENOME INC	$0.95	23.38%	47.74%	-45.40%	-74.32%	-83.33%	-92.69%	-97.40%	-99.85%	-100.00%	$18.89	$0.43	94.97%	121.45%	0.76	7,968,000	2,405.66%
CUE	CUE BIOPHARMA INC	$16.12	-7.89%	-13.93%	-17.63%	-48.13%	-45.30%	-13.28%	-77.52%	-96.99%	N/A	$45.50	$4.97	64.57%	224.28%	1.56	275,000	87.07%
ALT	ALTIMMUNE INC	$1.65	2.17%	-20.91%	-32.30%	-42.88%	-45.53%	-59.48%	-32.58%	-85.26%	-99.81%	$6.44	$1.58	74.46%	4.11%	1.35	3,502,000	-71.88%
GPCR	STRUCTURE THERAPEUTICS INC	$20.00	0.81%	-1.72%	-10.35%	-63.44%	-47.48%	-42.86%	-63.42%	N/A	N/A	$94.90	$18.70	78.93%	6.95%	0.90	1,344,000	29.48%
NTLA	INTELLIA THERAPEUTICS INC	$9.70	-8.06%	-14.54%	-18.56%	-18.01%	-32.07%	11.88%	-59.26%	-92.74%	-40.31%	$18.48	$7.95	47.51%	22.01%	1.96	11,379,000	184.12%
COYA	COYA THERAPEUTICS INC	$3.13	-4.28%	4.68%	-30.06%	-32.98%	-31.06%	-47.48%	-37.52%	N/A	N/A	$6.62	$2.72	52.72%	15.07%	1.08	189,000	34.04%
TYRA	TYRA BIOSCIENCES INC	$20.03	1.32%	-5.32%	7.89%	-19.96%	-44.67%	28.45%	71.30%	-29.41%	N/A	$40.65	$14.84	50.74%	34.94%	1.27	375,000	-56.24%
DYN	DYNE THERAPEUTICS INC	$17.16	0.88%	-5.04%	12.16%	-33.90%	-6.94%	-8.87%	97.24%	17.45%	N/A	$27.31	$14.00	37.15%	22.57%	1.58	1,674,000	-27.60%
AARD	AARDVARK THERAPEUTICS INC	$1.33	-12.50%	13.68%	-67.08%	-79.25%	-79.82%	-87.75%	N/A	N/A	N/A	$16.60	$0.93	91.99%	43.01%	2.16	402,000	60.80%
VKTX	VIKING THERAPEUTICS INC	$29.22	5.95%	8.87%	9.64%	-11.29%	-7.82%	-25.08%	194.26%	386.19%	2,418.97%	$43.10	$23.82	32.20%	22.67%	1.24	8,838,000	303.38%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$3.39	-0.59%	10.42%	-29.08%	-66.37%	-72.10%	-69.38%	7.28%	-89.82%	-98.72%	$12.88	$2.81	73.68%	20.64%	1.36	566,000	-46.15%
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$12.50	-2.87%	8.41%	20.08%	-24.24%	-32.10%	-0.48%	-65.91%	26.07%	N/A	$23.29	$9.46	46.33%	32.14%	0.73	1,184,000	-22.05%
PROK	PROKIDNEY CORP	$1.05	-9.13%	-8.33%	-33.44%	-25.62%	-40.29%	-54.17%	-34.69%	-89.47%	N/A	$2.65	$0.87	60.57%	20.11%	1.37	1,292,000	18.86%
ABVC	ABVC BIOPHARMA INC	$0.91	-5.60%	-6.09%	-7.05%	-5.11%	-14.95%	-67.50%	-20.18%	-97.44%	N/A	$3.03	$0.71	70.01%	28.71%	0.73	37,500	-14.77%
SPRC	SCISPARC LTD	$0.35	-0.56%	-15.75%	-91.04%	-94.72%	-92.97%	-98.47%	-99.96%	-100.00%	N/A	$29.88	$0.35	98.82%	2.32%	0.70	50,300	-35.51%
RLYB	RALLYBIO CORP	$15.72	0.45%	-0.19%	-5.98%	-7.31%	9.55%	199.54%	-22.64%	-85.88%	N/A	$17.57	$3.67	10.55%	328.34%	1.08	10,900	-53.22%
HIND	VYOME HOLDINGS INC	$1.58	-3.07%	0.00%	-19.80%	-26.85%	-17.71%	-67.95%	-99.89%	-100.00%	-100.00%	$5.88	$1.53	73.13%	3.34%	0.54	3,000	-53.85%
REVB	REVELATION BIOSCIENCES INC	$4.27	-2.63%	9.64%	-16.55%	-45.11%	-41.97%	-83.30%	-99.98%	-100.00%	N/A	$40.60	$3.08	89.50%	38.47%	1.17	6,500	-5.80%
SAEN	GENENTA SCIENCE SPA	$0.65	4.17%	-2.26%	-9.97%	-50.00%	10.73%	-70.18%	-88.18%	N/A	N/A	$2.58	$0.55	74.81%	18.18%	0.47	18,900	1.07%
RADX	RADIOPHARM THERANOSTICS LTD	$0.76	-3.80%	-20.75%	-36.67%	-71.32%	-83.19%	-83.26%	N/A	N/A	N/A	$16.25	$0.74	95.32%	3.26%	0.41	22,100	-33.03%
PULM	PULMATRIX INC	$1.29	-0.77%	-6.52%	-6.52%	-14.57%	1.57%	-73.63%	-27.93%	-92.07%	-99.29%	$4.98	$1.06	74.10%	21.70%	0.49	5,700	-41.84%
SEER	SEER INC	$1.57	-1.26%	-3.68%	-25.59%	-25.24%	-11.30%	-23.04%	-1.26%	-94.83%	N/A	$2.38	$1.53	33.89%	2.61%	1.63	122,000	93.65%
SXTP	60 DEGREES PHARMACEUTICALS INC	$0.52	-0.19%	-12.94%	-42.44%	-56.10%	-65.47%	-88.93%	-99.64%	N/A	N/A	$8.62	$0.48	93.99%	7.92%	0.16	24,500	-73.94%
SNGX	SOLIGENIX INC	$0.32	0.00%	-4.48%	-3.03%	-16.01%	-11.85%	-76.81%	-95.20%	-99.85%	-99.97%	$1.70	$0.28	81.12%	14.29%	0.59	136,000	-33.00%
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	$0.40	-9.50%	-9.30%	-67.48%	-83.33%	-92.09%	-96.00%	-99.33%	-99.98%	-99.99%	$13.00	$0.39	96.92%	3.36%	0.96	95,000	39.71%
APRE	APREA THERAPEUTICS INC	$0.42	-5.45%	-19.69%	-30.67%	-38.00%	-52.73%	-65.04%	-89.57%	-99.57%	N/A	$1.49	$0.41	72.08%	1.46%	0.63	91,000	-38.93%
ALZN	ALZAMEND NEURO INC	$1.24	-4.62%	-12.06%	-8.15%	-15.07%	19.23%	-46.78%	-98.99%	-99.96%	N/A	$2.56	$0.85	51.56%	45.88%	1.03	38,800	63.71%
PPCB	PROPANC BIOPHARMA INC	$1.94	1.09%	9.66%	-52.95%	-84.09%	-91.65%	-99.01%	N/A	N/A	N/A	$315.00	$1.63	99.38%	19.08%	2.54	9,300	-57.34%
SKYE	SKYE BIOSCIENCE INC	$1.09	0.93%	10.10%	-28.76%	-74.82%	-83.38%	-90.05%	N/A	N/A	159.52%	$11.68	$0.50	90.67%	118.00%	1.16	65,000	-59.38%
SLBT	SL SCIENCE HOLDING LTD	$0.73	-4.84%	-22.49%	-52.48%	-73.17%	-91.75%	-93.01%	N/A	N/A	N/A	$14.50	$0.62	94.99%	17.26%	0.16	25,200	-5.62%
PPBT	PURPLE BIOTECH LTD	$1.63	4.49%	24.43%	19.85%	9.03%	-58.71%	-77.98%	-99.19%	-99.82%	-99.98%	$8.90	$0.91	81.69%	79.12%	0.55	61,000	-9.63%
PMCB	PHARMACYTE BIOTECH INC	$6.68	-12.54%	-2.34%	-1.21%	-36.08%	-56.70%	-55.50%	-83.57%	-87.40%	-88.32%	$28.69	$4.69	76.72%	42.40%	0.71	127,000	504.76%
PLYX	POLARYX THERAPEUTICS INC	$1.77	-5.85%	-1.67%	-8.76%	-29.20%	-47.40%	N/A	N/A	N/A	N/A	$48.91	$1.69	96.38%	4.73%	1.38	9,500	-4.04%
PLUR	PLURI INC	$1.05	-3.67%	-15.32%	11.70%	-36.79%	-70.09%	-74.88%	-79.56%	-95.52%	-99.16%	$4.12	$0.85	74.51%	23.53%	0.84	14,800	-21.69%
SNTI	SENTI BIOSCIENCES HOLDINGS INC	$0.14	-4.76%	-12.50%	-45.10%	-63.54%	-85.46%	-92.18%	-96.77%	-99.86%	N/A	$2.88	$0.14	95.14%	1.45%	1.41	82,000	-46.05%
QCLS	Q/C TECHNOLOGIES INC	$0.31	0.32%	-8.82%	-43.22%	-89.16%	-92.60%	-89.94%	-99.97%	-100.00%	-100.00%	$8.17	$0.30	96.21%	2.99%	1.25	136,000	-20.00%
DCOY	DECOY THERAPEUTICS INC	$0.98	-7.58%	-13.72%	-21.37%	-72.38%	-79.77%	-93.29%	-99.91%	-100.00%	-100.00%	$16.92	$0.90	94.24%	8.33%	0.41	104,000	131.11%
ACTU	ACTUATE THERAPEUTICS INC	$0.29	-3.72%	-13.37%	-38.84%	-70.77%	-90.40%	-95.15%	N/A	N/A	N/A	$7.90	$0.28	96.39%	0.71%	1.02	174,000	11.54%
APVO	APTEVO THERAPEUTICS INC	$0.59	-10.00%	-52.10%	-65.66%	-82.53%	-87.52%	-97.72%	-100.00%	-100.00%	-100.00%	$25.65	$0.59	97.68%	0.00%	0.93	111,000	-52.77%
PHIO	PHIO PHARMACEUTICALS CORP	$0.77	-5.05%	-3.75%	-17.45%	-29.27%	-31.77%	-46.08%	-91.62%	-99.53%	-100.00%	$1.88	$0.75	58.99%	2.80%	1.14	63,000	-11.76%
ATHE	ALTERITY THERAPEUTICS LTD	$1.96	-6.67%	-19.34%	-31.23%	-58.30%	-57.58%	-46.88%	-18.09%	-83.17%	-92.25%	$5.89	$1.70	66.73%	15.29%	0.69	110,000	53.63%
AEON	AEON BIOPHARMA INC	$0.15	-3.77%	-13.07%	-33.48%	-43.54%	-81.34%	-83.72%	-99.95%	-99.98%	N/A	$1.45	$0.13	89.45%	20.47%	0.30	786,000	216.94%
PASG	PASSAGE BIO INC	$4.25	5.99%	6.92%	16.76%	-7.10%	-23.01%	-50.18%	-64.58%	-97.50%	N/A	$20.00	$3.30	78.75%	28.98%	1.61	11,900	-5.56%
OTLK	OUTLOOK THERAPEUTICS INC	$0.41	-6.14%	-5.28%	-26.77%	-53.54%	79.57%	-71.90%	-94.89%	-98.94%	-99.93%	$2.54	$0.16	83.73%	156.52%	0.98	3,019,000	23.48%
HLSQ	TESSERA DEFENSE & HOMELAND SECURITY INC	$0.03	-19.35%	-81.20%	-90.38%	-98.39%	-99.60%	-99.96%	-100.00%	-100.00%	N/A	$85.00	$0.02	99.97%	13.64%	0.62	804,000	-51.15%
NRSN	NEUROSENSE THERAPEUTICS LTD	$1.69	-3.98%	0.60%	-51.58%	-80.93%	-89.85%	-90.79%	-83.07%	N/A	N/A	$25.40	$1.10	93.35%	53.64%	0.71	18,300	-38.18%
IMNN	IMUNON INC	$0.63	-1.56%	-25.44%	-41.12%	-60.13%	-75.77%	-84.86%	-95.74%	-99.67%	-99.98%	$4.35	$0.50	85.52%	26.00%	0.80	175,000	-91.99%
NORD	NORDICUS PARTNERS CORP	$2.51	-7.04%	-22.05%	-37.25%	14.09%	-28.29%	-49.80%	-68.63%	-78.17%	-89.96%	$5.15	$1.48	51.26%	69.59%	-0.09	9,900	1,137.50%
TRXB	TREX BIO INC	$13.67	-3.05%	3.09%	0.51%	N/A	N/A	N/A	N/A	N/A	N/A	$16.56	$12.50	17.46%	9.36%	1.28	62,700	37.50%
NIKI	NIKI BIOSOLUTIONS INC	$1.65	-2.94%	4.43%	-37.14%	-80.29%	-79.38%	-88.38%	-89.56%	-99.24%	N/A	$17.20	$1.42	90.41%	16.61%	0.74	6,000	-91.04%
NEUP	NEUPHORIA THERAPEUTICS INC	$2.55	-1.16%	-8.27%	-24.78%	-33.42%	-48.80%	-46.32%	-89.27%	N/A	N/A	$5.53	$2.49	53.89%	2.41%	0.75	15,000	-23.86%
FLNA	FILANA THERAPEUTICS INC	$0.43	-4.44%	-5.08%	-41.89%	-54.55%	-65.04%	-85.37%	-97.79%	-99.29%	-90.27%	$3.45	$0.42	87.54%	2.38%	1.23	318,000	-26.22%
NCNA	NUCANA PLC	$0.93	0.32%	-0.53%	-11.14%	-36.96%	-50.11%	-73.27%	-99.95%	-99.99%	N/A	$4.54	$0.88	79.45%	6.63%	1.13	12,800	-51.70%
NCEL	NEWCELX LTD	$2.61	-2.97%	-4.19%	-8.10%	-27.50%	-19.44%	-23.91%	-98.68%	-99.70%	N/A	$5.12	$1.83	49.02%	42.62%	0.39	12,000	-1.64%
TCRT	ALAUNOS THERAPEUTICS INC	$1.63	0.62%	-6.32%	-46.20%	-18.09%	-35.32%	-42.81%	-86.92%	-99.22%	-99.85%	$4.49	$0.72	63.70%	126.39%	1.10	33,800	-40.70%
TECH	BIO-TECHNE CORP	$72.80	-0.05%	0.03%	0.44%	0.87%	62.17%	19.84%	27.50%	-41.97%	173.30%	$72.88	$43.20	0.11%	68.52%	1.09	2,491,000	13.64%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$0.90	-1.96%	-24.37%	-64.00%	-74.25%	-89.36%	-95.04%	-99.45%	-99.90%	N/A	$18.60	$0.81	95.16%	11.52%	0.99	43,000	11.40%
MRKR	MARKER THERAPEUTICS INC	$0.87	-3.33%	-2.25%	-5.43%	-21.62%	-39.16%	-2.47%	-67.05%	-93.79%	-98.18%	$2.46	$0.87	64.63%	0.00%	1.02	76,000	-46.10%
QNRX	QUOIN PHARMACEUTICALS LTD	$3.70	-1.33%	1.37%	-10.84%	-38.84%	-37.39%	-72.43%	-97.32%	-99.99%	-100.00%	$23.50	$3.25	84.26%	13.85%	1.36	16,000	190.91%
MREO	MEREO BIOPHARMA GROUP PLC	$0.31	0.66%	8.48%	-4.06%	-0.32%	18.08%	-82.75%	-85.72%	-86.23%	N/A	$2.37	$0.20	87.05%	53.50%	1.27	871,000	23.02%
TIL	INSTIL BIO INC	$6.08	-2.56%	-10.98%	-1.62%	-16.37%	-24.19%	-56.29%	-15.56%	-98.55%	N/A	$14.54	$5.56	58.18%	9.35%	1.59	51,600	-47.35%
CDT	CDT EQUITY INC	$0.40	-9.71%	-69.47%	-95.56%	-99.97%	-100.00%	-100.00%	-100.00%	N/A	N/A	$291.25k	$0.38	100.00%	5.26%	0.16	777,000	48.57%
VTGN	VISTAGEN THERAPEUTICS INC	$0.18	0.56%	9.76%	-16.28%	-32.33%	-72.56%	-95.26%	-93.41%	-99.72%	-99.84%	$5.14	$0.16	96.50%	9.76%	1.78	419,000	-46.01%
MGX	METAGENOMI THERAPEUTICS INC	$0.69	-3.08%	-2.40%	-24.54%	-43.74%	-49.86%	-59.29%	N/A	N/A	N/A	$1.87	$0.60	62.99%	15.33%	1.08	119,000	-34.62%
TNYA	TENAYA THERAPEUTICS INC	$0.35	0.58%	-3.06%	-33.01%	-52.39%	-63.65%	-74.53%	-81.03%	-98.53%	N/A	$1.46	$0.30	76.10%	16.33%	1.89	1,308,000	-41.66%
TOVX	THERIVA BIOLOGICS INC	$0.14	-10.00%	-13.77%	-33.33%	-37.39%	-56.36%	-48.57%	-98.69%	-99.85%	-100.00%	$0.49	$0.14	70.73%	5.88%	0.98	772,000	50.49%
MENS	JYONG BIOTECH LTD	$1.76	4.76%	-2.22%	-13.73%	-14.56%	-12.87%	-95.40%	N/A	N/A	N/A	$40.25	$1.43	95.63%	23.08%	1.92	27,000	35.00%
TRAW	TRAWS PHARMA INC	$0.25	-11.93%	13.06%	-38.78%	-58.17%	-85.41%	-85.82%	-98.45%	-99.72%	-100.00%	$3.23	$0.22	92.23%	14.61%	1.12	531,000	-22.93%
MBIO	MUSTANG BIO INC	$0.42	-9.27%	6.58%	11.67%	-29.12%	-35.23%	-65.21%	-99.43%	-99.98%	N/A	$1.43	$0.35	70.56%	20.29%	1.44	19,500	-63.41%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Xeris Biopharma Holdings (NASDAQ:XERS)

Xeris Biopharma Holdings (NASDAQ:XERS) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Xeris Biopharma Holdings (NASDAQ:XERS) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: B.

Xeris Biopharma Holdings (NASDAQ:XERS) has a Due Diligence Score of 39, which is 15 points higher than the biotech industry average of 24.

XERS passed 13 out of 33 due diligence checks and has average fundamentals. Xeris Biopharma Holdings has seen its stock return 129.48% over the past year, overperforming other biotech stocks by 225 percentage points.

Xeris Biopharma Holdings has an average 1 year price target of $17.00, an upside of 2.04% from Xeris Biopharma Holdings's current stock price of $16.66.

Xeris Biopharma Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Xeris Biopharma Holdings, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Regeneron Pharmaceuticals (NASDAQ:REGN) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Regeneron Pharmaceuticals (NASDAQ:REGN) has a Due Diligence Score of 47, which is 23 points higher than the biotech industry average of 24.

REGN passed 18 out of 38 due diligence checks and has strong fundamentals. Regeneron Pharmaceuticals has seen its stock return 37.48% over the past year, overperforming other biotech stocks by 133 percentage points.

Regeneron Pharmaceuticals has an average 1 year price target of $904.29, a downside of -5.36% from Regeneron Pharmaceuticals's current stock price of $955.47.

Regeneron Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 24 analysts covering Regeneron Pharmaceuticals, 58.33% have issued a Strong Buy rating, 8.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Fennec Pharmaceuticals (NASDAQ:FENC) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Fennec Pharmaceuticals (NASDAQ:FENC) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

FENC passed 17 out of 33 due diligence checks and has strong fundamentals. Fennec Pharmaceuticals has seen its stock return 51.11% over the past year, overperforming other biotech stocks by 147 percentage points.

Fennec Pharmaceuticals has an average 1 year price target of $16.67, an upside of 43.43% from Fennec Pharmaceuticals's current stock price of $11.62.

Fennec Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Fennec Pharmaceuticals, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 8 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)

Rallybio (NASDAQ:RLYB) has an annual dividend yield of 86.26%, which is 73 percentage points higher than the biotech industry average of 12.82%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.74%, which is -6 percentage points lower than the biotech industry average of 12.82%.

Oramed Pharmaceuticals's dividend payout ratio of 7.1% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.45%, which is -8 percentage points lower than the biotech industry average of 12.82%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 48.3% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 0.7% over the last week. Oragenics was the among the top losers in the biotechnology industry, dropping -42.86% yesterday.

Oragenics shares are trading lower. The stock initially rallied yesterday after the company announced it had been granted an extension to regain NYSE compliance, but it has since reversed.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.55% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has dropped -14.28% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

3. Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics (NASDAQ:ZVRA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Zevra Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Zevra Therapeutics's stock has dropped -1.63% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

Are biotech stocks a good buy now?

62.71% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 79.98% over the next year.

2.25% of biotech stocks have a Zen Rating of A (Strong Buy), 3.83% of biotech stocks are rated B (Buy), 44.82% are rated C (Hold), 36.71% are rated D (Sell), and 12.39% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 18.56x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.